Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Flutter Entertainment
FLUT
|
+$849M |
| 2 |
Intuitive Surgical
ISRG
|
+$559M |
| 3 |
CDW
CDW
|
+$416M |
| 4 |
Philip Morris
PM
|
+$408M |
| 5 |
PACCAR
PCAR
|
+$325M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.92B |
| 2 |
TSMC
TSM
|
+$789M |
| 3 |
Microsoft
MSFT
|
+$708M |
| 4 |
JPMorgan Chase
JPM
|
+$636M |
| 5 |
Eli Lilly
LLY
|
+$561M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Financials | 19.51% |
| 3 | Healthcare | 12.79% |
| 4 | Industrials | 12.46% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Colliers International
CIGI
$8.4B
| $18.5M | 0.01% |
121,801
+58,858
| +94% | +$8.94M |
|
602
Cytokinetics
CYTK
$6.22B
| $18.2M | 0.01% |
344,448
+68,381
| +25% | +$3.61M |
|
603
Bio-Rad Laboratories Class A
BIO
$7.49B
| $18.1M | 0.01% |
54,163
-294,377
| -84% | -$98.5M |
|
604
Texas Roadhouse
TXRH
$11B
| $17.9M | 0.01% |
+101,094
| New | +$17.9M |
|
605
Berkshire Hathaway Class B
BRK.B
$1.06T
| $17.8M | 0.01% |
38,781
-2,248
| -5% | -$1.03M |
|
606
Astera Labs
ALAB
$38.3B
| $16.9M | 0.01% |
322,993
+231,585
| +253% | +$12.1M |
|
607
Cisco
CSCO
$269B
| $16.8M | 0.01% |
+315,640
| New | +$16.8M |
|
608
Vivid Seats
SEAT
$96.5M
| $16.6M | 0.01% |
224,808
+6,252
| +3% | +$463K |
|
609
Helmerich & Payne
HP
$2.07B
| $16.6M | 0.01% |
546,232
-381,034
| -41% | -$11.6M |
|
610
Smith Douglas Homes
SDHC
$958M
| $16.5M | ﹤0.01% |
437,863
-12,330
| -3% | -$466K |
|
611
Tenaris
TS
$18.5B
| $16.5M | ﹤0.01% |
518,818
-66,352
| -11% | -$2.11M |
|
612
Helen of Troy
HELE
$550M
| $16.4M | ﹤0.01% |
264,616
-57,727
| -18% | -$3.57M |
|
613
ATS Corp
ATS
$2.58B
| $16.1M | ﹤0.01% |
555,912
-10,498
| -2% | -$305K |
|
614
AvalonBay Communities
AVB
$27.4B
| $15.8M | ﹤0.01% |
70,207
-25,801
| -27% | -$5.81M |
|
615
Viking Therapeutics
VKTX
$2.91B
| $15.7M | ﹤0.01% |
248,269
+11,668
| +5% | +$739K |
|
616
Dropbox
DBX
$8.29B
| $15.7M | ﹤0.01% |
615,879
+123,000
| +25% | +$3.13M |
|
617
QuidelOrtho
QDEL
$1.88B
| $15.6M | ﹤0.01% |
341,060
-172,536
| -34% | -$7.87M |
|
618
Immunocore
IMCR
$1.83B
| $15.5M | ﹤0.01% |
498,221
+107,656
| +28% | +$3.35M |
|
619
Chewy
CHWY
$14.5B
| $15.5M | ﹤0.01% |
528,215
+24,798
| +5% | +$726K |
|
620
Endava
DAVA
$511M
| $15.4M | ﹤0.01% |
601,898
+141,250
| +31% | +$3.61M |
|
621
Adaptive Biotechnologies
ADPT
$1.89B
| $14.8M | ﹤0.01% |
2,881,364
-1,030,663
| -26% | -$5.28M |
|
622
Evergy
EVRG
$16.5B
| $13.5M | ﹤0.01% |
218,205
-650,950
| -75% | -$40.4M |
|
623
Roper Technologies
ROP
$55.2B
| $13.3M | ﹤0.01% |
23,965
-666
| -3% | -$371K |
|
624
WisdomTree India Earnings Fund ETF
EPI
$2.93B
| $13.2M | ﹤0.01% |
261,782
+23,893
| +10% | +$1.21M |
|
625
Tronox
TROX
$755M
| $12.2M | ﹤0.01% |
831,254
+126,846
| +18% | +$1.86M |
|